Zeke Capital Advisors’s Inhibikase Therapeutics IKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$46.9K Hold
2022
Q3
$85K Hold
2022
Q2
$70K Hold
2022
Q1
$139K Hold
2021
Q4
$138K Hold
2021
Q3
$178K Hold
2021
Q2
$263K Buy
2021
Q1
$113K Hold
2020
Q4
$130K Buy